Citadel Advisors’s RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share RCFA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-78,250
Closed -$3.94K 15826
2024
Q3
$3.94K Buy
78,250
+38,099
+95% +$2.26K ﹤0.01% 13609
2024
Q2
$2.58K Buy
40,151
+3,715
+10% +$220 ﹤0.01% 13669
2024
Q1
$1.96K Buy
+36,436
New +$2.33K ﹤0.01% 14064

Other funds holding RCFA.WS

Citadel Advisors's RCFA.WS Position: Q4 2024 in Review

Citadel Advisors sold out of RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (RCFA.WS) in Q4 2024, closing a stake of 78,250 shares — an estimated $3.94K sold.

Citadel Advisors first reported a position in RCFA.WS in Q1 2024 and held it in 3 quarters. The position peaked at $3.94K in Q3 2024. 1 fund tracked by Wall St. Rank holds RCFA.WS as of Q4 2024.

  • Citadel Advisors reported no remaining RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 78,250 RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q4 2024, an estimated $3.94K.
  • Citadel Advisors first reported a position in RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q1 2024 and held it in 3 quarters.
  • Citadel Advisors's RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $3.94K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.